- Home
- SUPN vs CNMD Comparison
SUPN vs CNMD Comparison
Compare SUPN & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- CNMD
- Stock Information
- Founded
- SUPN 2005
- CNMD 1970
- Country
- SUPN United States
- CNMD United States
- Employees
- SUPN N/A
- CNMD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SUPN Health Care
- CNMD Health Care
- Exchange
- SUPN Nasdaq
- CNMD Nasdaq
- Market Cap
- SUPN 2.6B
- CNMD 1.7B
- IPO Year
- SUPN 2012
- CNMD 1987
- Fundamental
- Price
- SUPN $45.46
- CNMD $52.91
- Analyst Decision
- SUPN Buy
- CNMD Hold
- Analyst Count
- SUPN 2
- CNMD 5
- Target Price
- SUPN $43.00
- CNMD $59.80
- AVG Volume (30 Days)
- SUPN 645.4K
- CNMD 322.7K
- Earning Date
- SUPN 11-03-2025
- CNMD 10-29-2025
- Dividend Yield
- SUPN N/A
- CNMD 1.51%
- EPS Growth
- SUPN 1411.53
- CNMD 12.82
- EPS
- SUPN 1.14
- CNMD 3.54
- Revenue
- SUPN $665,125,000.00
- CNMD $1,326,244,000.00
- Revenue This Year
- SUPN $4.84
- CNMD $6.73
- Revenue Next Year
- SUPN $17.69
- CNMD $5.45
- P/E Ratio
- SUPN $39.74
- CNMD $14.94
- Revenue Growth
- SUPN 5.55
- CNMD 3.94
- 52 Week Low
- SUPN $29.16
- CNMD $46.00
- 52 Week High
- SUPN $46.79
- CNMD $78.19
- Technical
- Relative Strength Index (RSI)
- SUPN 64.24
- CNMD 47.69
- Support Level
- SUPN $45.26
- CNMD $52.35
- Resistance Level
- SUPN $46.72
- CNMD $54.12
- Average True Range (ATR)
- SUPN 1.04
- CNMD 1.42
- MACD
- SUPN -0.24
- CNMD -0.19
- Stochastic Oscillator
- SUPN 55.96
- CNMD 19.26
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.